EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Synergic prognostic value of 3D CT scan subcutaneous fat and muscle masses for immunotherapy-treated cancer

Pierre Decazes iD, Samy Ammari, Younes Belkouchi, Léo Mottay, Littisha Lawrance, Antoine de Prévia, Hugues Talbot, Siham Farhane, Paul-Henry Cournède, Aurelien Marabelle iD, Florian Guisier, David Planchard und 5 weitere

Journal for ImmunoTherapy of Cancer · 2023

DOI: 10.1136/jitc-2023-007315 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, 2023. Verfasst von Pierre Decazes und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Henri Becquerel Cancer Center, 76000 Rouen, France pierre.decazes@chb.unicancer.fr. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Melanoma. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Regional Development Fund (ERDF) with the Normandy region.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Our aim was to explore the prognostic value of anthropometric parameters in a large population of patients treated with immunotherapy.

Methods

We retrospectively included 623 patients with advanced non-small cell lung cancer (NSCLC) (n=318) or melanoma (n=305) treated by an immune-checkpoint-inhibitor having a pretreatment (thorax-)abdomen-pelvis CT scan. An external validation cohort of 55 patients with NSCLC was used. Anthropometric parameters were measured three-dimensionally (3D) by a deep learning software (Anthropometer3DNet) allowing an automatic multislice measurement of lean body mass, fat body mass (FBM), muscle body mass (MBM), visceral fat mass (VFM) and sub-cutaneous fat mass (SFM). Body mass index (BMI) and weight loss (WL) were also retrieved. Receiver operator characteristic (ROC) curve analysis was performed and overall survival was calculated using Kaplan-Meier (KM) curve and Cox regression analysis.

Results

In the overall cohort, 1-year mortality rate was 0.496 (95% CI: 0.457 to 0.537) for 309 events and 5-year mortality rate was 0.196 (95% CI: 0.165 to 0.233) for 477 events. In the univariate Kaplan-Meier analysis, prognosis was worse (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsMelanomaAnimalsHumansPrognosisRetrospective StudiesMusclesImmune Checkpoint InhibitorsImmunotherapy

Stichwörter der Autor:innen

ImmunotherapyMelanomaNon-Small Cell Lung Cancer

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Henri Becquerel Cancer Center, 76000 Rouen, France pierre.decazes@chb.unicancer.fr.
  • QuantIF-LITIS (EA[Equipe d'Accueil] 4108), Faculty of Medicine, University of Rouen, 76000 Rouen, France.
  • Biomaps, UMR1281 INSERM, CEA, CNRS, University of Paris-Saclay, 94800 Villejuif, France.
  • Department of Imaging, Gustave Roussy Cancer Campus, University of Paris-Saclay, 94800 Villejuif, France.
  • Centre de Vision Numérique, CentraleSupélec, Inria, Université Paris-Saclay, 91190 Gif-Sur-Yvette, France.
  • Department of Nuclear Medicine, Henri Becquerel Cancer Center, 76000 Rouen, France.

ORCID-Profile: Pierre Decazes, Aurelien Marabelle

Förderung

  • European Regional Development Fund (ERDF) with the Normandy region

Zitieren

APA

Decazes, P., Ammari, S., Belkouchi, Y., Mottay, L., Lawrance, L., de Prévia, A., Talbot, H., Farhane, S., Cournède, P. H., Marabelle, A., Guisier, F., Planchard, D., Ibrahim, T., Robert, C., Barlesi, F., Vera, P., & Lassau, N. (2023). Synergic prognostic value of 3D CT scan subcutaneous fat and muscle masses for immunotherapy-treated cancer. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2023-007315

Vancouver

Decazes P, Ammari S, Belkouchi Y, Mottay L, Lawrance L, de Prévia A, et al. Synergic prognostic value of 3D CT scan subcutaneous fat and muscle masses for immunotherapy-treated cancer. Journal for ImmunoTherapy of Cancer. 2023. doi:10.1136/jitc-2023-007315

BibTeX
@article{Decazes2023,
  author = {Decazes, Pierre and Ammari, Samy and Belkouchi, Younes and Mottay, Léo and Lawrance, Littisha and de Prévia, Antoine and Talbot, Hugues and Farhane, Siham and Cournède, Paul-Henry and Marabelle, Aurelien and Guisier, Florian and Planchard, David and Ibrahim, Tony and Robert, Caroline and Barlesi, Fabrice and Vera, Pierre and Lassau, Nathalie},
  title = {Synergic prognostic value of 3D CT scan subcutaneous fat and muscle masses for immunotherapy-treated cancer},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2023},
  doi = {10.1136/jitc-2023-007315}
}
Kostenlos starten →